FOLR1 and neoplasm: CAR-modified T cells, for example, have the capacity to persist as memory cells in vivo27,28 although recent data demonstrated that FRα CAR T cells mediated antitumor activity against established TNBC tumor when FRα is expressed at higher levels,26 which has significant implications for pre-selection of TNBC patients based on accurately defined FRα expression.